Clinical trials
Completed Phase 2 Generalized Anxiety Disorder trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2008 | 6 |
| 2011 | 1 |
| 2012 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Engrail Therapeutics INC | 2 |
| Merck Sharp & Dohme LLC | 2 |
| University of California, Los Angeles | 2 |
| Biotie Therapies Inc. | 1 |
| ChemRar Research and Development Institute, LLC | 1 |
| Cybin IRL Limited | 1 |
| Definium Therapeutics US, Inc. | 1 |
| GlaxoSmithKline | 1 |
| Haukeland University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Generalized Anxiety Disorder | 24 |
| Anxiety Disorders | 10 |
| Phobia, Social | 6 |
| Anxiety, Separation | 5 |
| Alcoholism | 1 |
| Panic Disorder | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.